Nataliya A. Rozanova

Nataliya A. Rozanova

Auto-generated profile, based on publicly available information

Nataliya A. Rozanova

Research Center of Neurology

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
PTPavel P. Tregub
Pavel P. Tregub
YKYulia Komleva
Yulia Komleva
MKMaria V. Kukla
Maria V. Kukla
AAAnton Averchuk
Anton Averchuk
AVAnna Sergeevna Vetchinova
Anna Sergeevna Vetchinova
ASAlla Salmina
Alla Salmina
Brain plasticity is at the basis of many cognitive functions, including learning and memory. It includes several mechanisms of synaptic and extrasynaptic changes, neurogenesis, and the formation and elimination of synapses. The plasticity of synaptic transmission involves the expression of immediate early genes (IEGs) that regulate neuronal activity, thereby supporting learning and memory. In addition, IEGs are involved in the regulation of brain cells’ metabolism, proliferation, and survival, in the establishment of multicellular ensembles, and, presumably, in cell competition in the tissue. In this review, we analyze the current understanding of the role of IEGs (c-Fos, c-Myc, Arg3.1/Arc) in controlling brain plasticity in physiological and pathological conditions, including brain aging and neurodegeneration. This work might inspire new gene therapy strategies targeting IEGs to regulate synaptic plasticity, and potentially prevent or mitigate neurodegenerative diseases.

6 December 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
NKNataliya A. Kolotyeva
Nataliya A. Kolotyeva
AGAlexander A. Groshkov
Alexander A. Groshkov
NRNataliya A. Rozanova
Nataliya A. Rozanova
ABArseniy K. Berdnikov
Arseniy K. Berdnikov
SNSvetlana V. Novikova
Svetlana V. Novikova
MPMikhail A. Piradov
Mikhail A. Piradov
NAD+ plays a pivotal role in energy metabolism and adaptation to external stimuli and stressful conditions. A significant reduction in intracellular NAD+ levels is associated with aging and contributes to the development of chronic cardiovascular, neurodegenerative, and metabolic diseases. It is of particular importance to maintain optimal levels of NAD+ in cells with high energy consumption, particularly in the brain. Maintaining the tissue level of NAD+ with pharmacological tools has the potential to slow down the aging process, to prevent the development of age-related diseases. This review covers key aspects of NAD+ metabolism in terms of brain metabolic plasticity, including NAD+ biosynthesis and degradation in different types of brain cells, as well as its contribution to the development of neurodegeneration and aging, and highlights up-to-date approaches to modulate NAD+ levels in brain cells.

29 September 2023 in Annals of Clinical and Experimental Neurology
Verified
Journal Article
Open access
PDF file
MRMaria V. Ryazanova
Maria V. Ryazanova
AAAnton Averchuk
Anton Averchuk
ASAlla V. Stavrovskaya
Alla V. Stavrovskaya
NRNatalia A. Rozanova
Natalia A. Rozanova
SNSvetlana V. Novikova
Svetlana V. Novikova
РВРязанова Мария Владимировна
Рязанова Мария Владимировна
Introduction. Arc/Arg3.1 is a common marker of neuronal activation for learning and memorizing. Some experimental data show the Arc/Arg3.1 expression in the post-mitotic neurons of the neurogenic niches. At the same time, we still have to understand the importance of such an expression for neurogenesis induced by the learning or memorizing processes, in health and in disease. Objective: to evaluate the changes in Arc/Arg3.1 expression in the post-mitotic neurons and to assess the proliferative activity of the neurogenic niche cells in Alzheimer's disease animal models. Materials and methods. We divided the C57Bl/6В mice into 2 groups: experimental (n = 15) and control (n = 15). The experimental group were injected with the amyloid- oligomers 2535 in their CA1 hippocampal region while the control mice received normal saline injections in the same region. Passive Avoidance Test (PAT) was used to assess the cognitive functions from the day 9 after the intervention. One hour after each test session we collected the samples of brain tissues to immunohistochemically assess them for the Arc/Arg3.1 expression and PCNA cell proliferation marker. Results. At day 11 the count of Arc/Arg3.1+NeuN+ cells in the subgranular zone had significantly increased. In animal neurodegeneration models the 1st and 2nd PAT sessions were associated with a significant increase in Arc/Arg3.1+NeuN+ cells, although by the day 11 their count significantly decreased. The count of Arc/Arg3.1+ cells in the subventricular and subgranular zones had increased after the 3rd PAT session in the control group while in Alzheimer's disease animal models this was observed only after the 2nd PAT session. Preserved Arc/Arg3.1 expression in the subventricular zone is associated with the increased PCNA cell prolifera- tion marker expression. At the same time, the toxic effect of the amyloid- oligomers suppressed the cells' proliferative activity in the subgranular zone at day 9. Conclusions. Despite the toxic effect of the amyloid- oligomers 2535, the post-mitotic neurons of the neurogenic niches retained the ability to express Arc/Arg3.1 in vivo. The obtained results show a transient increase in sensitivity of the post-mitotic neurons of the neurogenic niches for the learning stimuli in the early stages of the Alzheimer-type neurodegeneration.

26 June 2025 in Annals of Clinical and Experimental Neurology
Verified
Journal Article
Open access
PDF file
AAAnton Averchuk
Anton Averchuk
MKMaria V. Kukla
Maria V. Kukla
NRNatalia A. Rozanova
Natalia A. Rozanova
ASAlla V. Stavrovskaya
Alla V. Stavrovskaya
ASAlla Salmina
Alla Salmina
Introduction. Various animal models are employed to uncover the mechanisms of Alzheimer’s disease (AD) pathogenesis. Understanding brain damage pathogenesis in animal models of neurodegenerative diseases and identifying common patterns inherent to all relevant models is essential for adequate interpretation of findings, development of new models, as well as prevention and therapy strategies. The study aimed to assess neurogenesis and remodeling of the microvasculature in the subgranular zone (SGZ) of the hippocampal dentate gyrus in mice with two AD models. Materials and methods. The study employed two in vivo Alzheimer’s disease models: 1) animals with intrahippocampal administration of amyloid-β protein fragment Aβ25–35; 2) 5xFAD transgenic mice. Cognitive functions were evaluated using a passive avoidance test. On days 7 and 28 post-training, we assessed vascular network branching and density in the hippocampus using Evans Blue with subsequent software-based analysis of skeletonized images, analyzed proliferative activity of neuronal and endothelial cells, and their subpopulation composition using BrdU assay and multiparameter immunostaining of brain thin sections. Results. Animals following intrahippocampal Aβ25 -35 administration demonstrated enhanced neurogenesis and neoangiogenesis over 28 days post-training, unlike 5xFAD mice which showed delayed and less pronounced proliferation of neuronal cells in the SGZ alongside transient increases in proliferating endothelial cells. Both AD models exhibited divergent changes in tip and stalk cell counts within the hippocampal SGZ, indicating non-productive neoangiogenesis confirmed by reduced vascular branching and density in the SGZ of animals from both models. Conclusion. Cognitive deficits associated with experience-induced neurogenesis and cerebral angiogenesis mechanisms in the hippocampal neurogenic niche differ between AD models representing sporadic and familial variants, highlighting the need for fundamentally different approaches to pathogenetic therapy targeting non-productive angiogenesis and aberrant brain plasticity in various Alzheimer’s type neurodegeneration scenarios.

Verified
Journal Article
Open access
PDF file
NKNataliya A. Kolotyeva
Nataliya A. Kolotyeva
FGFrida N. Gilmiyarova
Frida N. Gilmiyarova
AAAnton Averchuk
Anton Averchuk
TBTatiana Ivanovna Baranich
Tatiana Ivanovna Baranich
NRNataliya A. Rozanova
Nataliya A. Rozanova
ASAlla Salmina
Alla Salmina
The development of brain in vitro models requires the application of novel biocompatible materials and biopolymers as scaffolds for controllable and effective cell growth and functioning. The “ideal” brain in vitro model should demonstrate the principal features of brain plasticity like synaptic transmission and remodeling, neurogenesis and angiogenesis, and changes in the metabolism associated with the establishment of new intercellular connections. Therefore, the extracellular scaffolds that are helpful in the establishment and maintenance of local microenvironments supporting brain plasticity mechanisms are of critical importance. In this review, we will focus on some carbohydrate metabolites—lactate, pyruvate, oxaloacetate, malate—that greatly contribute to the regulation of cell-to-cell communications and metabolic plasticity of brain cells and on some resorbable biopolymers that may reproduce the local microenvironment enriched in particular cell metabolites.

20 January 2025 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
MKM. V. Kukla
M. V. Kukla
AAAnton Averchuk
Anton Averchuk
ASAlla V. Stavrovskaya
Alla V. Stavrovskaya
NRN. A. Rozanova
N. A. Rozanova
ABA. K. Berdnikov
A. K. Berdnikov
ASAlla Salmina
Alla Salmina
Aim. To evaluate the expression of VEGFR1 and VEGFR2 and the maturity of endothelial cells in neurogenic niches in the model of Alzheimer’s disease.Materials and methods. The study was carried out on 6-month-old male C57BL/6 mice. The experimental group (n = 15) received 2 µl of 1 mM Aβ25-35 solution in the CA1 hippocampal region, while the control group (n = 15) received normal saline. Brain plasticity was assessed at day 10, 17, and 38 after surgery by the passive avoidance test. The expression of VEGFR1, VEGFR2, and CLDN5 was assessed by immunohistochemistry and the Image ExFluorer imaging system.Results. In the control group, cognitive training stimulated angiogenesis in the neurogenic niches of the brain, which was accompanied by the formation of microvasculature with fully mature endothelium. In the experimental group, an early and pronounced increase in the VEGFR1 expression was observed by day 7 after cognitive training, which was followed by impaired barrier formation and high VEGFR2 expression by day 28 after cognitive training. These changes were associated with the formation of small vessels with structural incompetence of endothelial cells.Conclusion. Angiogenesis in neurogenic niches of the animals with the model of Alzheimer’s disease is characterized by incompetent mechanisms regulating the subpopulation composition of endothelial cells, impaired stabilization of the endothelial layer, and a decrease in the maturation rate of endothelial cells in newly formed microvessels by the time of cognitive deficit manifestation. This may contribute to microcirculatory dysfunction and impaired neurogenesis in neurogenic niches as well as to the development of pathological permeability and neuroinflammation. On the whole, the disruption of angiogenesis in neurogenic niches observed in the animal model of Alzheimer’s disease suggests a potential contribution of this mechanism to the development of aberrant brain plasticity.